Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Race Oncology Ltd. ( (AU:RAC) ) has shared an update.
Racura Oncology Ltd has applied for quotation on the ASX of 1,434,699 new fully paid ordinary shares under its ticker RAC. The new securities, issued on May 4, 2026, expand the company’s listed share capital and provide additional equity instruments for existing and prospective investors.
The issuance follows the exercise or conversion of existing options or other convertible securities, reflecting uptake of these instruments by holders. This move modestly dilutes existing shareholders but signals confidence from option and convertible holders, incrementally strengthening Racura Oncology’s capital base for its ongoing operations in cancer-focused initiatives.
More about Race Oncology Ltd.
Racura Oncology Ltd, listed on the ASX under the code RAC, operates in the oncology sector, focusing on the development of cancer-related therapies or technologies. The company targets investors in the biotech and healthcare markets seeking exposure to oncology-focused innovation.
Average Trading Volume: 196,609
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$488.3M
Learn more about RAC stock on TipRanks’ Stock Analysis page.